1 / 12

Alopecia Treatment Market Analysis | CMI

Read here the latest updates on the Alopecia Treatment Market Analysis published by CMI team

Shweta2707
Download Presentation

Alopecia Treatment Market Analysis | CMI

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. ALOPECIA TREATMENT MARKET ANALYSIS • Alopecia Treatment Market - Global Forecast to 2026, by Disease Type (Androgenic Alopecia, Alopecia Areata, and Others), by Drug Type (Topical Agents, 5 AR Inhibitors, Corticosteroids, and Others), by Gender (Male and Female), by Route of Administration (Oral, Topical, and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2018 - 2026 • The global alopecia treatment market size was valued at US$ 7,325.0 million in 2017, and is expected to exhibit a CAGR of 4.9% over the forecast period (2018–2026).

  3. Figure 1. Global Alopecia Treatment Market Value (US$ Mn), by Region, 2018

  4. Market Drivers • Increasing product approvals, product launches, and robust pipelines are expected to propel the market growth • Rising product launch and robust pipelines are expected to drive the global Alopecia Treatment Market. For instance, in November 2018, Fidia Pharma launched Trinov hair growth lotion for hair growth in Italy. Furthermore, in September 2018, Eli Lilly and Company initiated phase 2 clinical trial to assess the safety and efficacy of Baricitinib drug in treating patients with alopecia areata. The study is estimated to complete in August 2022. • Rising initiatives such as crowdfunding campaigns and increasing collaboration by the market players is expected to bolster the market growth. For instance, in 2018, HairClone, a U.K. based company working on cellular hair restoration therapies, launched its public crowdfunding campaign. The company collaborated with Capital Cell, a crowdfunding company. Similarly, in May 2013, RepliCel Life Sciences Inc. and Shiseido Company, Limited announced collaboration and technology development transfer framework agreement for RepliCel’s RCH-01 hair regeneration technology.

  5. Figure 2. Global Alopecia Treatment Market Share (%), by Disease Type, 2018 and 2026

  6. Increasing prevalence of Alopecia Areata and higher focus on advancing research in the North America are expected to bolster the market growth • North America holds dominant position in the global alopecia treatment market, owing to increasing prevalence of Alopecia Areata and active research activities by market players. For instance, according to the National Alopecia Areata Foundation (NAAF), 2017, alopecia areata affects around 6.8 million people in the U.S. with a lifetime risk of 2.1%. Moreover, the NAAF is focused on broadening research efforts through two committees, including the Basic Research Advisory Council (BRAC), and the Clinical Research Advisory Council (CRAC), in order to advance the Alopecia Areata Treatment Development Program

  7. Increasing acquisition strategies in the region by the market players are major factor expected to propel the market growth. For instance, in August 2017, Aclaris Therapeutics, Inc. acquired Confluence Life Sciences, Inc., which expanded Aclaris’ inflammation and immunology pipeline with the addition of Confluence’s lead product candidates CDD-450, topical Janus kinase inhibitors, and IL2-inducible T-cell kinase inhibitor programs. • Moreover, collaboration of market players with regulatory authorities as well as other government organizations is further expected to support growth of the North America alopecia treatment market over the forecast period. For instance in April, 2019, Precision Therapeutics Inc., Helomics, and the National Alopecia Areata Foundation (NAAF), entered into an agreement to treat people affected by an autoimmune skin disease called alopecia areata. The agreement was intended to provide a next-generation patient registry to drive research on new treatments for people with this disease.

  8. Key Players • Major players operating in the global alopecia treatment market include Histogen Inc., Cipla Limited, Aclaris Therapeutics, Inc., Concert Pharmaceuticals, Inc., Merck & Co., Inc., Daiichi Sankyo Company, Limited, and Sun Pharmaceutical Industries Ltd.

  9. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • Reference : https://www.coherentmarketinsights.com/market-insight/alopecia-treatment-market-1847

  10. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  11. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

  12. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related